FinTech & InsurTech: Fireside chat with Krishna Chandran, solarisBank and Jan Wouter Kleinjan, CarNext.com at the NOAH Conference Berlin 2019, 13-14 June - STATION.
FinTech & InsurTech: Fireside chat with Krishna Chandran, solarisBank and Jan Wouter Kleinjan, CarNext.com at the NOAH Conference Berlin 2019, 13-14 June - STATION.
Revolutionary Consumer Products: Company presentation by Aalok Y Shukla, Straight Teeth Direct at the NOAH Conference Berlin 2019, 13-14 June - STATION.
Think Big, Think Global. Grow Your Business Internationally - NOAH19 BerlinNOAH Advisors
Google for Startups: Panel with Julienne Ernst and Jan Michel Vette, Google and Gaston Torun, Bettzeit at the NOAH Conference Berlin 2019, 13-14 June, STATION.
Ecommerce, Marketplaces & Classifieds: Company presentation by Federico Sargenti, Supermercato24 at the NOAH Conference Berlin 2019, 13-14 June, STATION.
Fintech & Insurtech - Payments: Company presentation by Yuval Ziv, CCO at SafeCharge at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
Ecommerce, Marketplaces & Classifieds: Company presentation by Waldemar Moss and Piotr Stach, Expondo at the NOAH Conference Berlin 2019, 13-14 June, STATION.
Ecommerce, Marketplaces & Classifieds - B2B Marketplaces: Company presentation by Patrick Horka, Co-Founder of Optune at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
Revolutionary Consumer Products: Company presentation by Aalok Y Shukla, Straight Teeth Direct at the NOAH Conference Berlin 2019, 13-14 June - STATION.
Think Big, Think Global. Grow Your Business Internationally - NOAH19 BerlinNOAH Advisors
Google for Startups: Panel with Julienne Ernst and Jan Michel Vette, Google and Gaston Torun, Bettzeit at the NOAH Conference Berlin 2019, 13-14 June, STATION.
Ecommerce, Marketplaces & Classifieds: Company presentation by Federico Sargenti, Supermercato24 at the NOAH Conference Berlin 2019, 13-14 June, STATION.
Fintech & Insurtech - Payments: Company presentation by Yuval Ziv, CCO at SafeCharge at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
Ecommerce, Marketplaces & Classifieds: Company presentation by Waldemar Moss and Piotr Stach, Expondo at the NOAH Conference Berlin 2019, 13-14 June, STATION.
Ecommerce, Marketplaces & Classifieds - B2B Marketplaces: Company presentation by Patrick Horka, Co-Founder of Optune at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
Digital Health: Company presentation by Shishir Singhee, Founder & CEO of Medloop, at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
Digital Health: Company presentation by Cristian Pascual, CEO and Co-founder of Mediktor, at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
Startup Stage - Healthcare - Presentation by Emil Kendziorra, Co-Founder & CEO of Medlanes at the Axel Springer NOAH Conference Berlin 2016, Tempodrom on the 8th of June 2016.
Startup Stage - Healthcare - Presentation by Marcel Muenster, Founder & CEO of TraveDoc at the NOAH Conference Berlin 2017, Tempodrom on the 22nd of June 2017.
Startup Stage - PropTech - Presentation by Naushard Jabir, Co-Founder & CEO of Vida at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Industrial Digitalisation: Company presentation by Aisha Raheem, Executive Director at Farmz2U, at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
With a focus on providing high-quality, lower-cost care, the healthcare industry has been looking to the retail industry for strategies used to engage and empower consumers. Lessons learned include how to use the retail setting as a medium for providing care and how to engage consumers outside of the care setting by using technology.
What is often neglected when assessing retail industry tactics is their core competency of using data insights to motivate and incentivize changes in consumer behavior. Connected Health solutions provide streams of valuable information that can be mined and analyzed to achieve business objectives.
Perficient's healthcare and retail experts demonstrated how data can be leveraged to:
-Transform passive recipients of care into active participants in care
-Mass customize messaging aligned with population health initiatives
-Achieve outreach objectives that convert unknown consumers into patients/members
-Improve care and lower healthcare costs
Online Content - Presentation by David Meinertz, Co-Founder & MD of DrEd Online Doctor at the NOAH Conference London 2016, Old Billingsgate on the 11th of November 2016.
Regaining the trust of HNW and UHNW investors with advice: independence, obje...Scorpio Partnership
Presentation by Sebastian Dovey, Managing Partner of Scorpio Partnership, global leaders in supplying financial research, world wealth reports and HNW insight to the wealth management industry.
Startup Stage - Recruitment - Presentation by Carl Hoffmann, Founder & MD of Talentry at the NOAH Conference Berlin 2017, Tempodrom on the 23rd of June 2017.
Official speaker book for the NOAH 2019 Conference in Tel Aviv with comprehensive background information on all presenting speakers and their companies.
Official speaker book for the NOAH 2018 Conference in Tel Aviv with comprehensive background information on all presenting speakers and their companies.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
12. 90% $11B
due to inefficient
communication
of provider / payer
communication completed by
phone or fax
80%
$1.7B
U.S. annual malpractice costs from
communication failures
Source: CRICO Strategies
Source: Council for Affordable Quality Healthcare
Source: Imprivata Report
WASTED
Poor communications in
U.S. healthcare cost almost
2.000
LIVESSource: CRICO Strategies
of medical errors stem from
lack of communication during
care transition
Source: Frost & Sullivan
13. 8 in 10
patients select providers on
convenience factors alone
Insurance coverage (46%)
Doctor/nurse conduct (44%)
Brand reputation (40%)
Quality of care (35%).
Source: NRC Health
14. 9 in 10
patients would leave their
current provider for one
that offers "streamlined,
comprehensive
communications and
technology"
Source: NRC Health
15. 8 in 10
patients said they’d like to
communicate with their
doctor’s office via text.
Source: NRC Health
16. 99%text message
open rate
Source: SinglePoint
90%text messages are read
within 3 minutes of
being received
Source: SinglePoint
33%average email open rate for
healthcare emails
Source: HubSpot
~30%average patient portal
adoption
19. 3hrs
saved per day
per practice using
Klara
92%
Klara customers:
“helps them provide
a great patient
experience”
81%
Klara customers:
“helps their practice
run smoothly and
efficiently”
80%
Patients using Klara
in the average
practice
20. 42
different specialties
StatesUsed in
403x users, usage and
revenue last year
Some of the best investors on
board:
80%Patients using Klara
in the average practice
THOUSANDS
HC providers and hundreds
of thousands of patients
24. Where there’s a phone,
There will be K L A R A.
@simonbolz
s.bolz@klara.com
25. Selected Completed NOAH Transactions
Focus on Leading European Internet companies
Covering over 400 companies across 25 online
verticals, a broad range of over 500 investors as
well as 100+ online-focused corporates
Deep understanding of industry dynamics
Ability to add value beyond banking advice
Facilitates overall process and minimizes
management distraction
NOAH Advisors is globally well connected
and has direct access to virtually all key
players in the industry
Knowledge of and strong relationships with
potential buyers’ key decision makers
Proactively finds and unlocks attractive
investment opportunities for leading investors
Annual NOAH Conference in its 10th year
Over 40 years of combined relevant M&A experience
Routine execution of M&A and financing transactions
with sizes of several billion euros
30 successfully completed NOAH Advisors transactions
underline successful transfer of M&A competencies to
the Internet sector
Entrepreneurial mind-set, focused on growing the
business and establishing a reputation for excellence
Ability to deliver top results in short time frames
Highly success-based compensation structures align
interests of clients and NOAH Advisors, and demonstrate
conviction to deliver top results
Creative deal solutions
Unique Industry Know-How
Unmatched Network and Relationships
Strong Investment Banking Competence
Full Commitment - We Are Entrepreneurs!
EUROPE’S LEADING INTERNET
CORPORATE FINANCE BOUTIQUE®
The NOAH Advisors Core Banking Team
Marco Rodzynek
Managing Director & Founder
Jan Brandes
Managing Director
Nikhil Parmar
Director
Olek Skwarczek
Associate
Lukas Schlund
Analyst
December 2014 October 2014
Sale of 100% of
for $800m to
Exclusive Financial Advisor to
Fotolia and the Selling Shareholders
Sale of 100% of
for €80m to
Exclusive Financial Advisor to
Trovit and its Shareholders
October 2016
Investment in
Exclusive Financial Advisor to KäuferPortal
and its Shareholders
by
84% Ownership
December 2016
August 2017
Financial Advisor to Silver Lake
Financial Advisor to EMK Capital
Investment in
Acquisition of a Majority Stake in
by
by
at a valuation of $200m
November 2019 July 2019
September 2018
Financial Advisor to MagicLab
Financial Advisor to AU10TIX
and its shareholders
Financial Advisor to 10bis
and its shareholders
Acquisition of a 79% stake in $60m Investment in
Sale of 100% in
by
at a valuation of ~$3 billion
at a valuation of $260m by
for €135m to
10Bis